Pfizer agrees to pay $345 million to resolve EpiPen lawsuit

6 monate vor

Pfizer has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive practices by the drugmaker and Mylan, the company that markets the emergency allergy treatment. #Pfizer #Mylan #EpiPen #News #Reuters Subscribe: Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled. Get the latest news on: Follow Reuters on Facebook: Follow Reuters on Twitter: Follow Reuters on Instagram:
Aus der Quelle lesen